DigestRedComo funciona
Red
/
Empresas
En
No verificado

Encoded Therapeutics Inc.

Sobre qué escribimos

BiotecnologíaEventosFarmacéuticaMedicina - VariosSalud

14 Comunicados de prensa

Ver todos los comunicados de prensa
09/09/2026
Salud
Biotecnología
Medicina - Varios
Farmacéutica
Encoded Therapeutics Raises $275 Million in Series F Financing to Advance ETX101 Through Pivotal Development and Accelerate its Precision Genetic Medicines Neurology Pipeline
Fuente
Encoded Therapeutics Inc.
Editor
Business Wire
1.00
0
02/09/2026
Eventos
Industria
Biotecnología
Salud
Farmacéutica
Medicina - Varios
Encoded Therapeutics to Present New Data on ETX101 Gene Therapy for Dravet Syndrome at the 16th European Epilepsy Congress
Fuente
Encoded Therapeutics Inc.
Editor
Business Wire
1.00
0
12/05/2026
Eventos
Ferias y Congresos
Industria
Ciencia
Biotecnología
Farmacéutica
Sanidad
Salud
Medicina - Varios
Encoded Therapeutics Presents New Preclinical Data at ASGCT 2026 Highlighting Precision Vector Engineering Across Neurology Programs
Fuente
Encoded Therapeutics Inc.
Editor
Business Wire
1.00
0
08/01/2026
Ciencia
Higiene alimentaria
Biotecnología
Medicina - Varios
Salud
Farmacéutica
Sanidad
Eventos
Encoded Therapeutics Highlights Progress in Dravet Syndrome Program and Pipeline Ahead of Company Presentation at 44th Annual J.P. Morgan Healthcare Conference
Fuente
Encoded Therapeutics Inc.
Editor
Business Wire
1.00
0
05/01/2026
Eventos
Salud
Biotecnología
Medicina - Varios
Farmacéutica
Encoded Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026
Fuente
Encoded Therapeutics Inc.
Editor
Business Wire
1.00
0
16/12/2025
Mercado laboral
Salud
Biotecnología
Medicina - Varios
Farmacéutica
Encoded Therapeutics Strengthens Clinical Leadership Team with Appointment of Professor Joseph Sullivan, M.D., as Vice President of Clinical Development
Fuente
Encoded Therapeutics Inc.
Editor
Business Wire
1.00
0
05/12/2025
Ciencia
Farmacéutica
Ir de compras
Biotecnología
Infancia
Medicina - Varios
Asistencia a la infancia
Higiene alimentaria
Salud
Eventos
Industria
Encoded Therapeutics Presents Positive Interim Efficacy Data from Initial Dose Levels of Phase 1/2 Trials Evaluating ETX101 Gene Therapy in Dravet Syndrome
Fuente
Encoded Therapeutics Inc.
Editor
Business Wire
1.00
0
01/12/2025
Ciencia
Higiene alimentaria
Biotecnología
Medicina - Varios
Salud
Farmacéutica
Sanidad
Eventos
Industria
Encoded Therapeutics to Present Interim Phase 1/2 Clinical Data on ETX101, the First One-time Gene Therapy in Development for Dravet Syndrome, at the 2025 American Epilepsy Society Annual Meeting
Fuente
Encoded Therapeutics Inc.
Editor
Business Wire
1.00
0
09/10/2025
Ciencia
Biotecnología
Medicina - Varios
Sanidad
Farmacéutica
Salud
Industria
New Preclinical Data from Encoded Therapeutics Demonstrate Therapeutic Potential of its One-time, Non-opioid Gene Therapy Candidate for Chronic Pain
Fuente
Encoded Therapeutics Inc.
Editor
Business Wire
1.00
0
02/09/2025
Salud
Higiene alimentaria
Biotecnología
Medicina - Varios
Farmacéutica
Industria
Encoded Therapeutics Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for ETX101 in SCN1A+ Dravet Syndrome
Fuente
Encoded Therapeutics Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0